IL1B and atherosclerosis: In a study we included (Zhang and Liu, 2023), it was shown that Sal B could exert anti-inflammatory activity by inhibiting the STAT3/NF-κB signalling pathway and suppressing the expression of the inflammatory factors IL-1β, IL-6, and TNF-α, thereby attenuating atherosclerosis.